T. Sugimoto

2.4k citations
23 papers · 241 indexed · h-index 9
Topics
Nuclear physics research studies (6 papers)Synthesis and Characterization of Heterocyclic Compounds (5 papers)Synthesis and Biological Evaluation (5 papers)

In The Last Decade

T. Sugimoto

20 papers receiving 233 citations

Peers

T. Sugimoto
Comparison fields: 5 of 74
  • Molecular Biology 101
  • Materials Chemistry 51
  • Organic Chemistry 48
  • Clinical Biochemistry 29
  • Epidemiology 20
Replace J. Junge with:
J. Junge United States
T. N. Solie United States
Emilia T. Mollova United States
Inna Levin Israel
U. Theilen Germany
N. Owens United Kingdom
P.L. Davies United Kingdom
Takeshi Nakao Japan
Helmut Kallwass Canada
Leonidas Emmanouilidis Switzerland
T. Sugimoto relative to J. Junge United States J. Junge's profile →
Citations per field
00.5×10×
J. Junge · 1×
Citations per year

Countries citing papers authored by T. Sugimoto

Since Specialization
Citations

This map shows the geographic impact of T. Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Sugimoto more than expected).

Fields of papers citing papers by T. Sugimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Sugimoto. The network helps show where T. Sugimoto may publish in the future.

Co-authorship network of co-authors of T. Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of T. Sugimoto. A scholar is included among the top collaborators of T. Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Sugimoto. T. Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 1
3 3
4 1
5 4
6 0
7 8
8 16
9 9
10 6
11 30
12 2
13 8
14 35
15 71
16 2
17 0
18 7
19 3
20 3

About T. Sugimoto

T. Sugimoto is a scholar working on Nuclear and High Energy Physics, Radiation and Clinical Biochemistry, having authored 23 papers that have together received 241 indexed citations. Recurring topics across this work include Nuclear physics research studies (6 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Clinical Biochemistry (29 citations), Organic Chemistry (48 citations) and Molecular Biology (101 citations). T. Sugimoto has collaborated with scholars based in Japan, Belgium and United States. Frequent co-authors include Shinya Matsuura, Toshiharu Nagatsu, M. Goto, Kazuyoshi Ikeda, Hiroshi Kasai, Yoshiko Mizuno, Mario Zama, Teppei Goto, Hitoshi Matsumoto and Koichi Sugimoto. Their work appears in journals such as Biochemistry, Clinical Chemistry and Medicinal Research Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026